⌘K

Gossamer Bio, Inc. (GOSS)

$0.88 -0.91% $-0.00 Healthcare

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colonystimulating factor 1 receptor, or CSF1R, and c-KIT inhibitor for the treatment of pulmonary arterial hypertension; GB004, a gut-targeted, oral small molecule for the treatment of inflammatory bowel disease; GB5121, an oral, irreversible, covalent, small molecule inhibitor of Bruton's Tyrosine Kinase for the treatment of primary central nervous system lymphoma; and GB7208, an oral, small molecule, BTK inhibitor for the treatment of multiple sclerosis. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds; and Aerpio Pharmaceuticals, Inc. to develop and commercialize GB004 and related compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. Gossamer Bio, Inc. was incorporated in 2015 and is headquartered in San Diego, California.

Market cap

$198.83M

CEO

Mr. Faheem Hasnain

Full time employees

185.00

Headquarters

San Diego, CA

IPO Date

Feb 08, 2019

Price-to-earnings (PE) Ratio

-4.63

Earnings-per-share (EPS)

$-0.19

Cash ratio (TTM)

1.92

Current ratio (TTM)

8.21

Net profit margin (TTM)

-78.78%

PE ratio (TTM)

-2.48

PEG ratio (TTM)

0.02

Price-to-book ratio (TTM)

2.46

Price-to-sales ratio (TTM)

1.96

Quick ratio (TTM)

8.21

Return on assets (TTM)

-21.65%

Return on equity (TTM)

-117.33%

Similar stocks (16)

Akero Therapeutics, Inc.

AKRO

$34.45 -1.20% $-0.42

Uptrend

Replimune Group, Inc.

REPL

$12.44 1.88% $0.23

Uptrend

Stoke Therapeutics, Inc.

STOK

$13.88 4.60% $0.61

Uptrend

Terns Pharmaceuticals, Inc.

TERN

$7.30 3.40% $0.24

Neutral

Alector, Inc.

ALEC

$5.75 1.95% $0.11

Neutral

Amylyx Pharmaceuticals, Inc.

AMLX

$6.70 2.45% $0.16

Neutral

4D Molecular Therapeutics, Inc.

FDMT

$8.12 -1.93% $-0.16

Downtrend

Biomea Fusion, Inc.

BMEA

$8.18 0.00% $0.00

Downtrend

Inozyme Pharma, Inc.

INZY

$4.02 -1.95% $-0.08

Downtrend

Nuvectis Pharma, Inc.

NVCT

$10.81 29.62% $2.47

Neutral

Acumen Pharmaceuticals, Inc.

ABOS

$3.27 3.15% $0.10

Neutral

Black Diamond Therapeutics, Inc.

BDTX

$3.29 3.46% $0.11

Downtrend

X4 Pharmaceuticals, Inc.

XFOR

$0.62 0.13% $0.00

Downtrend

Kronos Bio, Inc.

KRON

$0.82 -8.33% $-0.08

Downtrend

Passage Bio, Inc.

PASG

$0.61 -5.88% $-0.04

Downtrend

Lyra Therapeutics, Inc.

LYRA

$0.27 0.98% $0.00

Downtrend

ETF Exposure (13)

Schwab U.S. Small-Cap ETF

SCHA

0.0049784015%

$27.66 0.69% $0.19

Uptrend

Schwab U.S. Broad Market ETF

SCHB

5.344752e-4%

$23.24 0.48% $0.11

Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

$50.70 0.68% $0.34

Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

$50.69 0.68% $0.34

Uptrend

Vanguard Balanced Index Fund

VBINX

$50.69 0.68% $0.34

Uptrend

Vanguard Health Care Index Fund

VHT

$277.47 0.77% $2.11

Neutral

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$150.28 0.69% $1.03

Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

$102.36 0.69% $0.70

Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

$102.34 0.69% $0.70

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

$144.39 0.45% $0.64

Uptrend

Vanguard Total Stock Market Index Fund

VTI

$296.71 0.47% $1.38

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

$144.36 0.44% $0.63

Uptrend

Vanguard Extended Market Index Fund

VXF

$198.20 0.74% $1.45

Uptrend

Downtrend

Similar stocks (16)

Akero Therapeutics, Inc.

AKRO

$34.45 -1.20% $-0.42

Uptrend

Replimune Group, Inc.

REPL

$12.44 1.88% $0.23

Uptrend

Stoke Therapeutics, Inc.

STOK

$13.88 4.60% $0.61

Uptrend

Terns Pharmaceuticals, Inc.

TERN

$7.30 3.40% $0.24

Neutral

Alector, Inc.

ALEC

$5.75 1.95% $0.11

Neutral

Amylyx Pharmaceuticals, Inc.

AMLX

$6.70 2.45% $0.16

Neutral

4D Molecular Therapeutics, Inc.

FDMT

$8.12 -1.93% $-0.16

Downtrend

Biomea Fusion, Inc.

BMEA

$8.18 0.00% $0.00

Downtrend

Inozyme Pharma, Inc.

INZY

$4.02 -1.95% $-0.08

Downtrend

Nuvectis Pharma, Inc.

NVCT

$10.81 29.62% $2.47

Neutral

Acumen Pharmaceuticals, Inc.

ABOS

$3.27 3.15% $0.10

Neutral

Black Diamond Therapeutics, Inc.

BDTX

$3.29 3.46% $0.11

Downtrend

X4 Pharmaceuticals, Inc.

XFOR

$0.62 0.13% $0.00

Downtrend

Kronos Bio, Inc.

KRON

$0.82 -8.33% $-0.08

Downtrend

Passage Bio, Inc.

PASG

$0.61 -5.88% $-0.04

Downtrend

Lyra Therapeutics, Inc.

LYRA

$0.27 0.98% $0.00

Downtrend

ETF Exposure (13)

Schwab U.S. Small-Cap ETF

SCHA

0.0049784015%

$27.66 0.69% $0.19

Uptrend

Schwab U.S. Broad Market ETF

SCHB

5.344752e-4%

$23.24 0.48% $0.11

Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

$50.70 0.68% $0.34

Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

$50.69 0.68% $0.34

Uptrend

Vanguard Balanced Index Fund

VBINX

$50.69 0.68% $0.34

Uptrend

Vanguard Health Care Index Fund

VHT

$277.47 0.77% $2.11

Neutral

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$150.28 0.69% $1.03

Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

$102.36 0.69% $0.70

Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

$102.34 0.69% $0.70

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

$144.39 0.45% $0.64

Uptrend

Vanguard Total Stock Market Index Fund

VTI

$296.71 0.47% $1.38

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

$144.36 0.44% $0.63

Uptrend

Vanguard Extended Market Index Fund

VXF

$198.20 0.74% $1.45

Uptrend